SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from ClearPoint Neuro, Inc. (CLPT) (CIK 0001285550) (CLPT) — Oct 6, 2016

ClearPoint Neuro, Inc. (CLPT) (CIK 0001285550)
Date: Oct. 6, 2016 · CIK: 0001285550 · Accession: 0001534424-16-001080

Offering / Registration Process Regulatory Compliance Financial Reporting

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-213896

Date
October 6, 2016
Author
MRI Interventions
Form
CORRESP
Company
ClearPoint Neuro, Inc. (CLPT) (CIK 0001285550)

Letter

Re:

October 6, 2016

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

MRI Interventions, Inc.

Registration Statement on Form S-1

File No. 333-213896

REQUEST FOR ACCELERATION OF EFFECTIVENESS

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, MRI Interventions, Inc. (the “Company”) hereby respectfully requests acceleration of the effectiveness of the Company’s Registration Statement on Form S-1, File Number 333-213896, so that it will be declared effective on October 11, 2016 at 9:01 a.m. Eastern Time, or as soon as practicable thereafter.

This letter will confirm that the Company acknowledges that:

· should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

· the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

· the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Please contact our legal counsel, Richard F. Mattern, of Bass, Berry & Sims PLC, at (901) 543-5933, if you have any questions concerning this request.

Sincerely,
MRI Interventions,
Inc.

Show Raw Text
CORRESP
1
filename1.htm

October 6, 2016

VIA
EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

    Re:

    MRI Interventions, Inc.

    Registration Statement on Form S-1

    File No. 333-213896

    REQUEST FOR ACCELERATION OF EFFECTIVENESS

Ladies and Gentlemen:

In accordance with Rule
461 under the Securities Act of 1933, as amended, MRI Interventions, Inc. (the “Company”) hereby respectfully
requests acceleration of the effectiveness of the Company’s Registration Statement on Form S-1, File Number 333-213896, so
that it will be declared effective on October 11, 2016 at 9:01 a.m. Eastern Time, or as soon as practicable thereafter.

This letter will confirm
that the Company acknowledges that:

 · should the Securities and Exchange Commission (the “Commission”)
or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking
any action with respect to the filing;

 · the action of the Commission or the staff, acting pursuant to delegated
authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy
of the disclosure in the filing; and

 · the Company may not assert staff comments and the declaration of
effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the
United States.

Please contact our legal
counsel, Richard F. Mattern, of Bass, Berry & Sims PLC, at (901) 543-5933, if you have any questions concerning this request.

Sincerely,

MRI Interventions,
Inc.

    By:
    /s/ Harold A. Hurwitz

    Name:
    Harold A. Hurwitz

    Title:
    Chief Financial Officer and Secretary